Login

Categories

Consumer Corporate Energy Entertainment Experts Financials Healthcare Industrial Law Markets Media Mining Private Equity Real Estates Sports Startups Technology Venture Capital

Recent Videos

00:10:00
Exclusive Interview with President & CEO Tim Heenan and Chairman Patrick Evans | Tim Heenan - PRESIDENT, CEO & DIRECTOR of Mirasol Resources Ltd.
00:10:00
Mitre Mining (ASX: MMC) Seizes Chilean Acquisition for Major Silver-Gold Resource Boost | Ray Shorrocks - Interim Executive Director of Mitre Mining Corporation Ltd.
00:10:00
HALO Trust and MMD Demining Sizer: Clearing Zimbabwe's Mines for a Safer Future | Chad Cretney - VP of MMD Mineral Sizing (Canada) Inc.
00:00:00
SELLAS Life Sciences Group - Licensed Asset Aims To Prolong Survival in Cancer Patients - Dr. Angelos Stergiou, President and CEO of SELLAS Life Sciences Group
00:00:00
Saniona President and CEO Rami Levin provides an overview of near-term milestones for key clinical programs - Rami Levin, CEO, Saniona
00:00:00
RLS Global - Naventus Life Science Summit - Karin Fischer, CEO, RLS Global
00:00:00
ReWalk Robotics Ltd RWLK CEO Larry Jasinski
00:00:00
RedHill Biopharma (NASDAQ: RDHL) Presenting the company - Gay Goldberg, CBO, Redhill Biopharma Ltd
00:00:00
Redx Pharma lands biggest deal to date with sale of KRAS inhibitor programme to Jazz Pharma - Lisa Anson Chief Executive Officer, Redx Pharma
00:00:00
Redx Pharma achieves milestone with dosing of first participant in Phase 1 clinical trial for RXC008 - Lisa Anson Chief Executive Officer, Redx Pharma
00:00:00
Redx Pharma begins testing lead drug in phase II trial for idiopathic pulmonary fibrosis - Lisa Anson Chief Executive Officer, Redx Pharma
00:00:00
RedX Pharma drug candidate pipeline underpins strong first half progress - Lisa Anson Chief Executive Officer, Redx Pharma
00:00:00
Redx Pharma presents at European Society for Medical Oncology (ESMO) Congress - Lisa Anson Chief Executive Officer, Redx Pharma
00:00:00
Regeneus ASX:RGS May 2021 Business Update - Karolis Rosickas, CEO, Regeneus Ltd
00:00:00
Company update and season’s greetings from Regeneus Dec 2020 - Karolis Rosickas, CEO, Regeneus Ltd
00:00:00
ReNeuron / Michael Hunt, Chief Financial Officer, ReNeuron Group
00:00:00
ReNeuron Group's phase IIb stroke trial kicks off with first patient treated - Michael Hunt, Chief Financial Officer, ReNeuron Group
00:00:00
Michael Hunt CFO of ReNeuron Group (RENE) at SHARES Innovators and Investors Forum - Michael Hunt, Chief Financial Officer, ReNeuron Group
00:00:00
ReNeuron focus on new clinical trials - Michael Hunt, Chief Financial Officer, ReNeuron Group
00:00:00
Lots to look forward to' as ReNeuron gets go-ahead for phase IIb stroke trial - Michael Hunt, Chief Financial Officer, ReNeuron Group

© 2017 - Neuhu+